S.D.N.Y. Rejects Proposed Amended Complaint Alleging Manufacturer Of Liver Disease Drug Intended To Commit Fraud By Not Disclosing Serious Adverse Events

Gregg Weiner, Adam Harris, Life Sciences Litigation & Enforcement Team, S.D.N.Y. Rejects Proposed Amended Complaint Alleging Manufacturer Of Liver Disease Drug Intended To Commit Fraud By Not Disclosing Serious Adverse Events, Life Sciences Securities Litigation (September 21, 2020) [The Library at LexBlog, LEX-WK-707YZ43X, lexpid.org/707YZ43X]